Living Well with G-NETs: Long-Term Monitoring and Survivorship

Moving into the survivorship phase of a gastric neuroendocrine tumor (G-NET) diagnosis often requires a shift in mindset. For many, especially those with Type 1 or Type 2, the journey is less about a “cure” and more about managing a chronic, long-term condition with an excellent overall outlook ^[1][2].

The Surveillance “Standard”

Because G-NETs (particularly Type 1) have a high rate of local recurrence—meaning new, small tumors may appear in the stomach over time—lifelong monitoring is essential ^[3][1]. This does not mean the initial treatment failed; it is simply the nature of the underlying stomach environment ^[3].

• Type 1 & 2: Standard practice typically involves an upper endoscopy every 1 to 2 years ^[4][5]. The goal is to catch any new growths while they are still small (<10 mm) and can be easily managed ^[6].
• Type 3: Because these are more aggressive, surveillance is more intensive. It usually includes both endoscopies and regular imaging, such as CT scans, MRIs, or 68Gallium-DOTATATE PET scans, to monitor for any spread outside the stomach ^[7][8].

Managing the “Invisible” Side Effects and Diet

For patients with Type 1 G-NETs, the underlying chronic atrophic gastritis (stomach thinning) can cause nutritional issues that are just as important to manage as the tumors themselves ^[9]. Because atrophic gastritis leads to very low stomach acid, digestion may be impacted, and malabsorption can occur.

• Dietary Adjustments: Many patients find it helpful to eat smaller, more frequent meals. Working with a registered dietitian who understands low stomach acid (achlorhydria) can help you adjust your diet to minimize bloating and discomfort.
• Vitamin B12 & Iron: The stomach lining is responsible for absorbing these crucial nutrients. Many survivors develop pernicious anemia or iron deficiency and may require lifelong supplements or B12 injections ^[10][11].
• Vitamin D & Bone Health: Recent research has shown that Type 1 G-NET survivors have a significantly higher risk of Vitamin D deficiency and bone density loss (osteoporosis) than the general population ^[12]. Regular monitoring of these levels is a vital part of survivorship ^[12].

Special Considerations for Type 2 (MEN1)

If you have a Type 2 G-NET, you are likely part of a broader surveillance program for Multiple Endocrine Neoplasia Type 1 (MEN1). This involves a lifelong “roadmap” of monitoring other hormone-producing glands ^[13]:

• Parathyroid: Monitoring blood calcium and PTH levels.
• Pituitary: Periodic MRIs to check for small, benign growths.
• Pancreas: Imaging to monitor for other neuroendocrine tumors ^[14].

Living with “Scanxiety”

It is completely normal to feel a surge of anxiety in the weeks leading up to a scheduled endoscopy or scan—a phenomenon often called “scanxiety.”

• Focus on the Goal: Remember that for most G-NETs, the purpose of the scan is not to find an emergency, but to maintain the “early detection” that makes this disease so manageable ^[5].
• Recurrence is Not Failure: In Type 1 G-NETs, finding a new 5 mm polyp is common and usually has no impact on your overall life expectancy ^[3][1].
• Support Matters: Because G-NETs are rare, finding a community of other “NETies” can help normalize the experience of lifelong monitoring and provide a space to discuss the unique challenges of being a “rare disease survivor” ^[15].